Do You Qualify?

Phase III Trial of Combination Lomustine-Temozolomide Therapy for Newly Diagnosed Glioblastoma Patients

Are you a newly diagnosed glioblastoma patient interested in enrolling in the new phase III trial to test combination Temozolomide-Lomustine therapy?

  • This field is for validation purposes and should be left unchanged.

The current standard of care for glioblastoma consisting of radiation and chemotherapy is ineffective.

Help Us Transform Glioblastoma Therapy